|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1986-7-16
|
|
pubmed:abstractText |
A 23-year-old woman with systemic lupus erythematosus was found to have severe pulmonary hypertension with secondary patency of the foramen ovale. Infusion of hydralazine increased the basal right-to-left shunt and resulted in a dramatic fall in arterial oxygen pressure, with subsequent irreversible cardiovascular collapse. Vasodilator therapy appears to be hazardous in patients with severe pulmonary hypertension and patent foramen ovale.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
894-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:3709258-Adult,
pubmed-meshheading:3709258-Blood Pressure,
pubmed-meshheading:3709258-Cardiomyopathies,
pubmed-meshheading:3709258-Female,
pubmed-meshheading:3709258-Heart Septum,
pubmed-meshheading:3709258-Humans,
pubmed-meshheading:3709258-Hydralazine,
pubmed-meshheading:3709258-Hypertension, Pulmonary,
pubmed-meshheading:3709258-Lupus Erythematosus, Systemic,
pubmed-meshheading:3709258-Oxygen,
pubmed-meshheading:3709258-Partial Pressure,
pubmed-meshheading:3709258-Shock,
pubmed-meshheading:3709258-Vasodilator Agents
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
Danger of vasodilator therapy for pulmonary hypertension in patent foramen ovale.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
